TY  - CONF

T1  - Integrated Safety Update of Abrocitinib in 1014 Young Adult Patients Aged 18 to <40 Years With Moderate-to-Severe Atopic Dermatitis: Data From More Than 2250 Patient-Years With up to 4.5 Years of Exposure

JO  - JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

PY  - 2025/09/01

AU  - Simpson E

AU  - Irvine AD

AU  - Silverberg JI

AU  - Gold LFS

AU  - Cork MJ

AU  - Deleuran M

AU  - Geng B

AU  - Lumpan C

AU  - Selfridge A

AU  - Fan H

AU  - Koppensteiner H

ED  - 

VL  - 93

IS  - 3

SP  - AB234

EP  - AB234

Y2  - 2025/10/28

ER  -